Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Development of a CT-based Automated Radiomics Technique for Nodule Detection, Malignancy Prediction and Histological Subtyping of Lung Cancer. Alexander Nicol The Hong Kong Polytechnic University NLST Jan 26, 2022 NLST-877
Lung Abnormality Detection using Deep learning Harshil Soni System Level Solutions India Ptv.Ltd. NLST Jan 26, 2022 NLST-875
Deep learning AIDS medicine wei zhang East China Normal University NLST Jan 26, 2022 NLST-873
Fully automated end to end analysis of non-small-cell lung carcinoma using deep learning techniques Eranga Ukwatta University of Guelph NLST Jan 26, 2022 NLST-871
Unsupervised analysis of thorax CT datasets Marian Himstedt University of Luebeck NLST Jan 18, 2022 NLST-870
Federated Validation of Lung Nodule Detection Algorithms. Brian Ayers Gesund AI NLST Jan 18, 2022 NLST-869
Pan-cancer gene-environment interaction studies jianbo Tian School of Health Public Wuhan University PLCO Jan 18, 2022 PLCO-900
BMI and the risk of renal cell carcinoma : a case control study Benjamin Chung Stanford University PLCO Jan 18, 2022 PLCO-896
Radiomic analysis of Chest radiographs for prediction of lung cancer outcomes Anant Madabhushi Emory University PLCO Jan 18, 2022 PLCOI-887
Interpretable AI prediction of prostate tumor staging Matthias Weidemüller Universität Heidelberg PLCO Jan 18, 2022 PLCO-897
Association of dietary carrot intake with colorectal cancer incidence and mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial zongze Jiang West China Fourth Hospital PLCO Jan 18, 2022 PLCO-899
The influence of biological factors and environmental exposure on the occurrence and prognosis of various cancers and the construction of prediction models Xiaorong Yang Qilu Hospital of Shandong University PLCO Jan 13, 2022 PLCO-890
Development and evaluation of combined cancer screening strategies for high-risk populations of Prostate, Lung, Colorectal and Ovarian Cancers Huang Yubei Tianjin Medical University Cancer Institute and Hospital PLCO Jan 13, 2022 PLCO-895
Clinically Applicable Deep Learning Pipeline for Diagnosis of Mediastinal Neoplasms Hengrui Liang The First Affiliated Hospital of Guangzhou Medical University NLST Jan 12, 2022 NLST-868
Pulmonary Adenocarcinoma of Low Malignant Potential Eric Burks Boston University School Of Medicine NLST Jan 7, 2022 NLST-867
Threshold quantile regression models with applications to PSA data Eun Ryung Lee Sungkyunkwan University PLCO Jan 7, 2022 PLCO-893
Modeling risk for lung cancer using trans-ancestry polygenic risk score, blood biomarkers, and lifestyle behaviors Meng Zhu Nanjing Medical University PLCO Jan 7, 2022 PLCO-892
The timing between the diagnosis and the end of the last treatment in the cancer continuum in patients with colon cancer by TNM stages; and the impact of delays in the final survival of the patients, in PLCO, In the period available in the data set. Percy Guzman Percy Guzman PLCO Jan 7, 2022 PLCO-882
Chest Radiograph And Pathologic Phenotype For Biological Age Prediction Using Deep Learning – Training and Validation in Chinese Patients Varut Vardhanabhuti The University of Hong Kong PLCO Jan 5, 2022 PLCOI-820
Evaluating key determinants for the risk of second primary lung cancer among bladder cancer survivors using population-based screening trial data from the PLCO Summer Han Stanford University PLCO Jan 5, 2022 PLCO-886